Maximum precision 100% sensitivity, amplification of exons 5, 7 and 10 of the RHD gene.
Cost savings This test makes it possible to reduce the administration of anti-D immunoglobulins and optimise the management of RhD-negative patients (RH: -1).
Non-invasive method A simple maternal blood test is all that is needed.
Compliant with European regulations CE-IVD certified in accordance with Regulation (EU)2017/746.
Ease of integration Compatible with standard laboratory automation systems and protocols.